Setting a new standard

An advanced FFR pressure guidewire with fiber optic sensing technology.

Learn more about FFR solutions
OptoWire Deux

OptoWire Deux

Experienced an entirely new level of productivity with OptoWire Deux . The first Nitinol based FFR pressure guidewire with fiber optic sensing technology.

  • Optical coherence technology
  • First Nitinol & stainless steel construction
  • Reliable & fast recovery connectivity

More details
OptoMonitor

OptoMonitor

Easy cathlab integration and intuitive workflow. OptoMonitor offers an intuitive step-by-step workflow with state of the art touch screen.

  • Easy cathlab integration
  • Intuitive workflow
  • Perpetual system availability

More details

Fractional Flow Reserve Facts

DEFER study and the 5-year follow-up

A valid question. Is PCI necessary and beneficial for patient with a coronary stenosis without evidence of ischemia?

More details Read more about DEFER study and the 5-year follow-up
 

FAME study

Improved outcomes. Using fractional flow reserve (FFR) measurements during stenting procedures reduced MACE by 28% and a strong trend towards a lower rate of death, MI or the need for repeat revascularization in the FFR guided approach.

More details Read more about DEFER study and the 5-year follow-up
 

FAME II study

Better patient outcomes with FFR-Guided cardiac stenting. The use of FFR-guided PCI led to an 86 % decrease in risk of unplanned hospitalization for urgent revascularization, compared with medical treatment alone.

More details Read more about DEFER study and the 5-year follow-up

Experience an entirely new level of productivity with: our FFR products

About Opsens Medical

Established in 2003, Opsens Medical, a division of Opsens (TSX VENTURE: OPS) was founded on the belief that our innovative technologies will help to improve cardiovascular disease treatment.

Our ground-breaking solutions are designed to improve your success rate in the most challenging peripheral and coronary interventions. We combine the most innovative and reliable fiber optic sensing technology with advanced guidewire materials construction so that you can accomplish more in less procedure time and with lower overall cost.

Our goal is the same as yours: better outcomes.

More informations about us  

News & Events

See all
05 Jul
OPSENS Q3 RESULTS – SALES OF $2,125,000, UP 156% YEAR-OVER-YEAR
22 Jun
OPSENS: HEALTH CANADA APPROVAL FOR THE SALE OF OPTOWIRE II
17 May
OPSENS COMPLETES $5 MILLION PRIVATE PLACEMENT